|
|
Volumn 6, Issue 9, 1996, Pages 871-891
|
|
New antirejection drugs
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
15 DEOXYSPERGUALIN;
AZATHIOPRINE;
BREQUINAR;
CELL ADHESION MOLECULE;
CORTICOSTEROID;
CYCLOSPORIN A;
CYTOKINE;
IMMUNOMODULATING AGENT;
IMMUNOSUPPRESSIVE AGENT;
INTERCELLULAR ADHESION MOLECULE 1;
INTERCELLULAR ADHESION MOLECULE 1 ANTIBODY;
ISOXAZOLE DERIVATIVE;
LEFLUNOMIDE;
LFA 1 ANTIBODY;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 1;
LYMPHOCYTE FUNCTION ASSOCIATED ANTIGEN 3;
MIZORIBINE;
MONOCLONAL ANTIBODY;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
TACROLIMUS;
UNCLASSIFIED DRUG;
ALLOGRAFT;
ANIMAL MODEL;
CLINICAL PROTOCOL;
CLINICAL TRIAL;
DIARRHEA;
EFFECTOR CELL;
GRAFT REJECTION;
HUMAN;
IMMUNE RESPONSE;
IMMUNOMODULATION;
IMMUNOSUPPRESSIVE TREATMENT;
NONHUMAN;
PATENT;
REVIEW;
SIGNAL TRANSDUCTION;
T LYMPHOCYTE;
T LYMPHOCYTE ACTIVATION;
TRANSPLANTATION;
|
|
EID: 0029744906
PISSN: 13543776
EISSN: None
Source Type: Journal
DOI: 10.1517/13543776.6.9.871 Document Type: Review |
|
Times cited : (3)
|
|
References (0)
|
